Biswas Subhas C, Shi Yijie, Vonsattel Jean-Paul G, Leung Conrad L, Troy Carol M, Greene Lloyd A
Department of Pathology, Center for Neurobiology and Behavior and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
J Neurosci. 2007 Jan 24;27(4):893-900. doi: 10.1523/JNEUROSCI.3524-06.2007.
The molecules that mediate neuron death in Alzheimer's disease (AD) are largely unknown. We report that beta-amyloid (Abeta), a death-promoting peptide implicated in the pathophysiology of AD, induces the proapoptotic protein Bcl-2 interacting mediator of cell death (Bim) in cultured hippocampal and cortical neurons. We further find that Bim is an essential mediator of Abeta-induced neurotoxicity. Our examination of postmortem AD human brains additionally reveals upregulation of Bim in vulnerable entorhinal cortical neurons, but not in cerebellum, a region usually unaffected by AD. Accumulating evidence links inappropriate induction/activation of cell cycle-related proteins to AD, but their roles in the disease have been unclear. We find that the cell cycle molecule cyclin-dependent kinase 4 (cdk4) and its downstream effector B-myb, are required for Abeta-dependent Bim induction and death in cultured neurons. Moreover, neurons that overexpress Bim in AD brains also show elevated levels of the cell cycle-related proteins cdk4 and phospho-Rb. Our observations indicate that Bim is a proapoptotic effector of Abeta and of dysregulated cell cycle proteins in AD and identify both Bim and cell cycle elements as potential therapeutic targets.
在阿尔茨海默病(AD)中介导神经元死亡的分子在很大程度上尚不明确。我们报告称,β-淀粉样蛋白(Aβ)是一种与AD病理生理学相关的促死亡肽,它可在培养的海马体和皮质神经元中诱导促凋亡蛋白——细胞死亡的Bcl-2相互作用介质(Bim)。我们进一步发现,Bim是Aβ诱导的神经毒性的关键介质。我们对AD患者死后大脑的检查还发现,在内嗅皮质易损神经元中Bim上调,但在通常不受AD影响的小脑区域则不然。越来越多的证据表明,细胞周期相关蛋白的不适当诱导/激活与AD有关,但其在该疾病中的作用尚不清楚。我们发现,细胞周期分子细胞周期蛋白依赖性激酶4(cdk4)及其下游效应物B-myb是培养神经元中Aβ依赖性Bim诱导和死亡所必需的。此外,在AD大脑中过表达Bim的神经元也显示出细胞周期相关蛋白cdk4和磷酸化Rb水平升高。我们的观察结果表明,Bim是AD中Aβ和细胞周期蛋白失调的促凋亡效应物,并将Bim和细胞周期元件均确定为潜在的治疗靶点。